NCT05497843 2025-04-03
Chiauranib for Advanced or Unresectable Soft Tissue Sarcoma(STS)
Chipscreen Biosciences, Ltd.
Phase 2 Completed
Clinical Trials
9 trialsNCT04830813 2024-12-09
Phase 3 Clinical Study of Chiauranib Capsule in Patients With Small-cell Lung Cancer
Chipscreen Biosciences, Ltd.
Phase 3 Completed
NCT05371899 2024-07-15
Mass Balance Study of [14C]Chiauranib
Chipscreen Biosciences, Ltd.
Phase NA Completed
NCT03216343 2023-08-30
Phase Ib/II Study of Chiauranib in Patients With Small Cell Lung Cancer
Chipscreen Biosciences, Ltd.
Phase 1 Completed
NCT03974243 2022-03-09
Chiauranib in Combination With Chidamide in Patients With Relapsed/Refractory Non-Hodgkin's Lymphoma
Chipscreen Biosciences, Ltd.
Phase 1/2 Completed
NCT03245190 2021-06-18
Study of Chiauranib in Patients With Advanced Hepatocellular Carcinoma
Chipscreen Biosciences, Ltd.
Phase 1/2 Completed
NCT03901118 2021-03-19
Chiauranib in Combination With Chemotherapy in Patients With Ovarian Cancer
Chipscreen Biosciences, Ltd.
Phase 2 Completed
NCT03166891 2020-01-18
Phase Ib Study of Chiauranib in Patients With Ovarian Cancer
Chipscreen Biosciences, Ltd.
Phase 1/2 Completed
NCT02122809 2016-06-17
Phase I Study of Chiauranib in Patients With Advanced Solid Tumors
Chipscreen Biosciences, Ltd.
Phase 1 Completed